Ethics and Policy Core

道德和政策核心

基本信息

  • 批准号:
    10491803
  • 负责人:
  • 金额:
    $ 7.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-30 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The goal of the Penn Artificial Intelligence and Technology (PennAITech) Collaboratory is to identify, develop, evaluate, commercialize, and disseminate innovative technology for monitoring aging adults and persons with Alzheimer's disease and Alzheimer’s disease related dementias (AD/ADRD) in their home environment and the artificial intelligence (AI) methods and software for analyzing data generated by those technologies for improving clinical care. This will help aging Americans live safe, social, and engaged lives. To date, the science of AI and monitoring technologies has often outpaced existing ethical and policy frameworks, and the unique ethical and policy implications for older adults, including older adults experiencing cognitive decline/impairment and their care partners, have largely been overlooked. Therefore, there is a critical need for ethics and policy scholarship—in conversation both with the science of AI and monitoring technology and also with the science of aging and AD/ADRD—throughout the research phase, as well as during its translation into viable interventions. To address this need, the Ethics and Policy Core will work in close collaboration with the other PennAITech Collaboratory Cores with a focus on four key issues: promoting the autonomy of older adults by balancing considerations of usefulness and intrusiveness; protecting older adults in light of vulnerability due to cognitive and functional decline; mitigating bias and addressing health disparities, such as racial disparities and urban-rural disparities; and safeguarding the data privacy of older adults. In order to accomplish this, the Ethics and Policy Core has three aims: (1) to provide guidance and training to PennAITech Collaboratory-funded pilot project leaders, trainees, and industry leaders on ethical and policy issues encountered in researching and developing AI methods and technologies for healthy aging; (2) to examine the ethical and policy barriers to using AI methods and technologies for healthy aging from the perspective of diverse stakeholders, including healthy older adults, adults with AD/ADRD, and care partners; and (3) to serve as a national resource for the research community by disseminating guidelines and best practices related to developing AI methods and technologies for healthy aging and translating them into care with a focus on healthy older adults, adults with AD/ADRD, and care partners. This innovative and impactful Core will be led by Emily A. Largent, JD, PhD, RN, an authority on bioethical and policy issues in research and care involving older adults and persons living with AD/ADRD, and it will engage a multidisciplinary team of experts to reach its overarching goal.
项目概要 宾夕法尼亚大学人工智能与技术 (PennAITech) 合作实验室的目标是识别、开发、 评估、商业化和传播用于监测老年人和患有糖尿病的人的创新技术 家庭环境中的阿尔茨海默病和阿尔茨海默病相关痴呆症 (AD/ADRD) 以及 用于分析这些技术生成的数据的人工智能(AI)方法和软件 改善临床护理。这将帮助美国老年人过上安全、社交和参与的生活。迄今为止, 人工智能和监控技术的科学往往超越了现有的道德和政策框架,并且 对老年人(包括经历认知能力的老年人)独特的伦理和政策影响 衰退/损伤及其护理伙伴在很大程度上被忽视了。因此,迫切需要 道德和政策奖学金——与人工智能科学和监控技术的对话 还涉及衰老科学和 AD/ADRD——整个研究阶段以及翻译过程 采取可行的干预措施。为了满足这一需求,道德和政策核心将与 其他 PennAITech 合作核心重点关注四个关键问题: 促进老年人的自主权 通过平衡有用性和侵入性的考虑来成人;保护老年人 由于认知和功能下降而导致的脆弱性;减少偏见并解决健康差异,例如 种族差异和城乡差异;保护老年人的数据隐私。为了 为了实现这一目标,道德与政策核心有三个目标:(1) 为 PennAITech Collaboratory 资助的试点项目负责人、学员和行业领导者在道德和政策方面 健康老龄化人工智能方法和技术研发中遇到的问题; (2) 至 研究使用人工智能方法和技术实现健康老龄化的伦理和政策障碍 不同利益相关者的观点,包括健康老年人、患有 AD/ADRD 的成年人以及护理合作伙伴; (3) 通过传播指导方针和最佳方法,作为研究界的国家资源 与开发健康老龄化人工智能方法和技术并将其转化为护理相关的实践 重点关注健康老年人、患有 AD/ADRD 的成年人以及护理伙伴。这种创新且具有影响力的 Core 将由 Emily A. Largent 领导,她是法学博士、博士、注册护士,她是研究和政策领域生物伦理和政策问题的权威。 涉及老年人和 AD/ADRD 患者的护理,并将聘请多学科团队 专家以实现其总体目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Emily Largent其他文献

Emily Largent的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Emily Largent', 18)}}的其他基金

Adapting supported decision making to promote wellbeing and improve health outcomes for persons living with Alzheimer's disease and Alzheimer's disease related dementias
调整支持性决策,以促进阿尔茨海默病和阿尔茨海默病相关痴呆症患者的福祉并改善其健康结果
  • 批准号:
    10437135
  • 财政年份:
    2022
  • 资助金额:
    $ 7.55万
  • 项目类别:
Adapting supported decision making to promote wellbeing and improve health outcomes for persons living with Alzheimer's disease and Alzheimer's disease related dementias
调整支持性决策,以促进阿尔茨海默病和阿尔茨海默病相关痴呆症患者的福祉并改善其健康结果
  • 批准号:
    10624351
  • 财政年份:
    2022
  • 资助金额:
    $ 7.55万
  • 项目类别:
Ethics and Policy Core
道德和政策核心
  • 批准号:
    10685547
  • 财政年份:
    2021
  • 资助金额:
    $ 7.55万
  • 项目类别:
Ethics and Policy Core
道德和政策核心
  • 批准号:
    10274455
  • 财政年份:
    2021
  • 资助金额:
    $ 7.55万
  • 项目类别:
UNDERSTANDING HOW THE STUDY PARTNER REQUIREMENT IMPACTS THE DISCOVERY AND TRANSLATION OF PRECLINICAL ALZHEIMERS DISEASE
了解研究合作伙伴要求如何影响临床前阿尔茨海默病的发现和转化
  • 批准号:
    10683182
  • 财政年份:
    2019
  • 资助金额:
    $ 7.55万
  • 项目类别:
UNDERSTANDING HOW THE STUDY PARTNER REQUIREMENT IMPACTS THE DISCOVERY AND TRANSLATION OF PRECLINICAL ALZHEIMERS DISEASE
了解研究合作伙伴要求如何影响临床前阿尔茨海默病的发现和转化
  • 批准号:
    9980755
  • 财政年份:
    2019
  • 资助金额:
    $ 7.55万
  • 项目类别:
UNDERSTANDING HOW THE STUDY PARTNER REQUIREMENT IMPACTS THE DISCOVERY AND TRANSLATION OF PRECLINICAL ALZHEIMERS DISEASE
了解研究合作伙伴要求如何影响临床前阿尔茨海默病的发现和转化
  • 批准号:
    10403518
  • 财政年份:
    2019
  • 资助金额:
    $ 7.55万
  • 项目类别:
UNDERSTANDING HOW THE STUDY PARTNER REQUIREMENT IMPACTS THE DISCOVERY AND TRANSLATION OF PRECLINICAL ALZHEIMERS DISEASE
了解研究合作伙伴要求如何影响临床前阿尔茨海默病的发现和转化
  • 批准号:
    9806426
  • 财政年份:
    2019
  • 资助金额:
    $ 7.55万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了